Edwards Lifesciences (EW)

Edwards Lifesciences on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as orthopedic, prosthetic & surgical appliances & supplies.

Download CSV

9.5M

Short interest

settlement 2026-09-30

2.5

Days to cover

-0.7 days vs prior

63.1%

Short share of volume

2026-10-09

Fails to deliver

settlement 2026-09-09

Thu 29 Oct

Next earnings

estimated date

-$4.5M

Insider flow, 90 days

0 buys, 11 sells

As of 2026-10-09.

Short interest

FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in EW is 9,538,735 shares, up 516,671 shares over the last month. Over the last 48 readings it ranged from 5,640,466 shares (15 December 2025) to 12,376,285 shares (27 February 2026). At the reported average volume of 3.9M shares a day that is 2.5 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/ew" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-09-30	9,538,735	+5.0%	3,875,387	2.46
2026-09-15	9,088,401	+0.7%	2,880,751	3.15
2026-08-31	9,022,064	-11.9%	2,810,336	3.21
2026-08-14	10,241,231	+2.0%	3,263,390	3.14
2026-07-31	10,043,721	-11.5%	5,683,561	1.77
2026-07-15	11,352,019	-1.0%	4,522,301	2.51
2026-06-30	11,466,764	-2.8%	5,443,863	2.11
2026-06-15	11,797,466	-3.0%	4,914,670	2.40
2026-05-29	12,163,159	+6.8%	5,235,630	2.32
2026-05-15	11,394,337	+8.1%	4,480,101	2.54
2026-04-30	10,538,452	+12.9%	6,345,311	1.66
2026-04-15	9,331,359	-6.4%	4,742,330	1.97
2026-03-31	9,971,356	-8.9%	4,399,366	2.27
2026-03-13	10,945,893	-11.6%	5,059,115	2.16
2026-02-27	12,376,285	+56.6%	4,625,420	2.68
2026-02-13	7,902,820	-2.4%	6,178,363	1.28
2026-01-30	8,093,410	+2.2%	3,510,505	2.31
2026-01-15	7,916,291	+10.9%	3,850,667	2.06
2025-12-31	7,138,485	+26.6%	2,791,483	2.56
2025-12-15	5,640,466	-19.2%	3,017,679	1.87
2025-11-28	6,980,005	-28.6%	3,828,600	1.82
2025-11-14	9,771,913	+7.2%	3,745,459	2.61
2025-10-31	9,116,391	+17.1%	6,254,328	1.46
2025-10-15	7,787,459	+4.4%	4,052,352	1.92

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 9 October 2026, the short share of EW volume is 63.1%, up 5.6 points over the last five sessions. Over the last 30 readings it ranged from 26.8% (4 September 2026) to 80.8% (8 October 2026). The latest reading is 16.0 points above the 30-session average of 47.0%, on 1.6M shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-10-09	980K	1.6M	63.1%	67
2026-10-08	2.2M	2.7M	80.8%	0
2026-10-07	475K	1.3M	37.6%	85
2026-10-06	718K	1.4M	51.6%	4,809
2026-10-05	453K	1.1M	40.8%	1,734
2026-10-02	500K	871K	57.5%	101
2026-10-01	510K	1.3M	39.6%	2,203
2026-09-30	880K	1.6M	56.2%	276
2026-09-29	756K	1.2M	62.8%	1,682
2026-09-28	480K	1.2M	41.3%	3,314
2026-09-25	550K	1.5M	37.6%	38,962
2026-09-24	548K	1.2M	44.1%	489
2026-09-23	663K	1.5M	44.7%	1,464
2026-09-22	413K	1.3M	30.9%	4,554
2026-09-21	484K	1.3M	37.8%	1,870
2026-09-18	613K	1.2M	50.9%	19
2026-09-17	752K	1.3M	55.9%	5
2026-09-16	950K	1.9M	49.3%	33
2026-09-15	590K	1.6M	37.8%	63
2026-09-14	409K	983K	41.6%	637
2026-09-11	685K	1.6M	43.4%	878
2026-09-10	441K	806K	54.8%	481
2026-09-09	403K	922K	43.6%	3,435
2026-09-08	492K	1.0M	46.9%	44
2026-09-04	387K	1.4M	26.8%	59
2026-09-03	305K	696K	43.8%	9
2026-09-02	390K	953K	40.9%	8,163
2026-09-01	442K	1.0M	44.1%	31
2026-08-31	663K	1.3M	51.4%	1,137
2026-08-28	379K	708K	53.5%	254

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 9 September 2026, the fails-to-deliver balance in EW is 54 shares, down 40 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (18 August 2026) to 145,740 shares (29 June 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-09-09	54	$86.72	$5K
2026-09-08	94	$89.90	$8K
2026-09-03	14	$90.82	$1K
2026-09-01	443	$90.75	$40K
2026-08-28	658	$89.95	$59K
2026-08-27	1,971	$90.78	$179K
2026-08-24	2,037	$89.79	$183K
2026-08-18	1	$90.81	$91
2026-08-11	50,336	$92.03	$4.6M
2026-07-13	8,844	$92.21	$816K
2026-07-10	18,311	$91.33	$1.7M
2026-07-08	403	$94.82	$38K
2026-07-01	45	$90.46	$4K
2026-06-30	1,389	$91.18	$127K
2026-06-29	145,740	$90.78	$13.2M
2026-06-26	336	$89.72	$30K
2026-06-23	222	$85.88	$19K
2026-06-15	6	$85.11	$511
2026-06-08	11,098	$85.96	$954K
2026-06-03	3,704	$87.66	$325K
2026-05-28	2,272	$86.51	$197K
2026-05-14	5,572	$81.39	$454K
2026-05-13	23,698	$79.73	$1.9M
2026-04-15	3	$78.20	$235
2026-04-14	75	$78.12	$6K
2026-04-10	100	$79.15	$8K
2026-04-06	89	$81.05	$7K
2026-03-31	76	$79.50	$6K
2026-03-25	58	$81.69	$5K
2026-03-24	106	$82.02	$9K

Insider trades

SEC Form 4, newest first, 50 of 100 shown. JSON

Insiders at EW reported 11 open-market sells worth $4.5M in the last 90 days and no open-market buys. Latest filing: Lippis Daniel J. (CVP, TAVR) on 2026-10-08.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-10-08	Lippis Daniel J.	CVP, TAVR	Sell	619	$85.65	$53K	40K
2026-10-08	Lippis Daniel J.	CVP, TAVR	Option exercise	619	$72.68	$45K	41K
2026-09-14	Markowitz Wayne	CVP, JAPAC	Tax withholding	568	$84.37	$48K	19K
2026-09-13	Dahl Andrew M.	SVP, Corporate Controller	Tax withholding	253	$84.37	$21K	15K
2026-09-11	Markowitz Wayne	CVP, JAPAC	Tax withholding	355	$86.77	$31K	20K
2026-09-11	Lippis Daniel J.	CVP, TAVR	Sell	619	$87.51	$54K	40K
2026-09-11	Lippis Daniel J.	CVP, TAVR	Option exercise	619	$72.68	$45K	41K
2026-09-11	Chopra Daveen	CVP, TMTT, Surgical & IHFM	Tax withholding	398	$86.77	$35K	44K
2026-08-31	Dahl Andrew M.	SVP, Corporate Controller	Sell	544	$91.06	$50K	15K
2026-08-28	Bruls Annette	CVP, EMEACLA	Sell	3K	$89.98	$238K	18K
2026-08-26	Markowitz Wayne	CVP, JAPAC	Sell	1K	$91.47	$113K	20K
2026-08-26	Chopra Daveen	CVP, TMTT, Surgical & IHFM	Sell	31K	$90.99	$2.8M	44K
2026-08-26	Chopra Daveen	CVP, TMTT, Surgical & IHFM	Sell	1K	$91.76	$106K	75K
2026-08-26	Chopra Daveen	CVP, TMTT, Surgical & IHFM	Option exercise	32K	$72.68	$2.3M	76K
2026-08-11	Lippis Daniel J.	CVP, TAVR	Sell	619	$92.03	$57K	40K
2026-08-11	Lippis Daniel J.	CVP, TAVR	Option exercise	619	$72.68	$45K	41K
2026-07-30	Markowitz Wayne	CVP, JAPAC	Sell	146	$86.03	$13K	22K
2026-07-28	Markowitz Wayne	CVP, JAPAC	Sell	10K	$85.06	$819K	22K
2026-07-28	Markowitz Wayne	CVP, JAPAC	Option exercise	10K	$74.02	$713K	31K
2026-07-27	Zovighian Bernard J	CEO	Gift	320	$0.00	$0	12K
2026-07-27	Zovighian Bernard J	CEO	Sell	3K	$83.93	$245K	9K
2026-07-27	Zovighian Bernard J	CEO	Gift	320	$0.00	$0	99K
2026-07-11	Bruls Annette	CVP, EMEACLA	Tax withholding	109	$92.21	$10K	21K
2026-07-10	Lippis Daniel J.	CVP, TAVR	Sell	619	$91.70	$57K	40K
2026-07-10	Lippis Daniel J.	CVP, TAVR	Option exercise	619	$72.68	$45K	41K
2026-07-09	Mistras Theodora	CVP, Chief Financial Officer	Grant	12K	$0.00	$0	100K
2026-07-09	Mistras Theodora	CVP, Chief Financial Officer	Grant	88K	$0.00	$0	88K
2026-07-07	Lippis Daniel J.	CVP, TAVR	Tax withholding	377	$95.18	$36K	40K
2026-06-30	Lippis Daniel J.	CVP, TAVR	Option exercise	619	$72.68	$45K	41K
2026-06-30	Lippis Daniel J.	CVP, TAVR	Sell	619	$91.40	$57K	40K
2026-06-17	Zovighian Bernard J	CEO	Sell	523	$87.92	$46K	12K
2026-05-29	Dahl Andrew M.	SVP, Corporate Controller	Sell	568	$86.08	$49K	15K
2026-05-29	Dahl Andrew M.	SVP, Corporate Controller	Sell	568	$86.08	$49K	15K
2026-05-27	BOBO DONALD E JR	CVP,Strategy/Corp Development	Sell	23K	$86.42	$2.0M	99K
2026-05-22	Chopra Daveen	CVP, TMTT & Surgical	Sell	2K	$84.60	$127K	44K
2026-05-18	Lippis Daniel J.	CVP, TAVR	Sell	620	$81.14	$50K	40K
2026-05-18	Lippis Daniel J.	CVP, TAVR	Option exercise	620	$72.68	$45K	41K
2026-05-15	BOBO DONALD E JR	CVP,Strategy/Corp Development	Sell	8K	$81.82	$655K	31K
2026-05-15	BOBO DONALD E JR	CVP,Strategy/Corp Development	Sell	10K	$82.07	$818K	23K
2026-05-12	Zovighian Bernard J	CEO	Gift	27K	$0.00	$0	48K
2026-05-12	Zovighian Bernard J	CEO	Sell	36K	$77.92	$2.8M	12K
2026-05-12	Zovighian Bernard J	CEO	Sell	845	$78.40	$66K	48K
2026-05-12	Zovighian Bernard J	CEO	Gift	27K	$0.00	$0	99K
2026-05-11	Zovighian Bernard J	CEO	Gift	5K	$0.00	$0	22K
2026-05-11	Ullem Scott B.	CVP, Chief Financial Officer	Tax withholding	11K	$79.96	$880K	47K
2026-05-11	Ullem Scott B.	CVP, Chief Financial Officer	Option exercise	20K	$0.00	$0	58K
2026-05-11	Markowitz Wayne	CVP, JAPAC	Sell	593	$79.73	$47K	22K
2026-05-11	Zovighian Bernard J	CEO	Gift	5K	$0.00	$0	105K
2026-05-11	Lippis Daniel J.	CVP, TAVR	Tax withholding	362	$79.96	$29K	40K
2026-05-11	Zovighian Bernard J	CEO	Tax withholding	26K	$79.96	$2.1M	126K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

35 Form 144 notices on file for EW worth $40.4M at the prices reported; 9 in the last 90 days worth $9.2M. Latest: Dahl Andrew M. filed on 2026-08-31 to sell 544 shares ($50K) from 2026-08-31.

Filed	Seller	Shares	Market value	Of outstanding	Sale from	Broker
2026-08-31	Dahl Andrew M.Officer	544	$50K	0.000%	2026-08-31	Charles Schwab & Co., Inc.
2026-08-28	Bruls AnnetteOfficer	3K	$238K	0.000%	2026-08-28	Charles Schwab & Co., Inc.
2026-08-26	Markowitz WayneOfficer	1K	$113K	0.000%	2026-08-26	Charles Schwab & Co., Inc.
2026-08-26	Chopra DaveenOfficer	32K	$2.9M	0.006%	2026-08-26	Charles Schwab & Co., Inc.
2026-08-11	Lippis Daniel J.Officer	2K	$171K	0.000%	2026-08-11	Charles Schwab & Co., Inc.
2026-07-30	Ullem Scott B.Former Affiliate	50K	$4.6M	0.009%	2026-07-30	Charles Schwab & Co., Inc.
2026-07-30	Markowitz WayneOfficer	147	$13K	0.000%	2026-07-30	Charles Schwab & Co., Inc.
2026-07-28	Markowitz WayneOfficer	10K	$819K	0.002%	2026-07-28	Charles Schwab & Co., Inc.
2026-07-27	Zovighian Bernard JOfficer, Director	3K	$245K	0.001%	2026-07-27	Charles Schwab & Co., Inc.
2026-05-29	Ullem Scott B.Former Affiliate	64K	$5.6M	0.011%	2026-05-29	Charles Schwab & Co., Inc.
2026-05-29	Dahl Andrew M.Officer	568	$49K	0.000%	2026-05-29	Charles Schwab & Co., Inc.
2026-05-27	BOBO JR FAMILY TRUSTOfficer	23K	$2.0M	0.004%	2026-05-27	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-05-22	Chopra DaveenOfficer	2K	$127K	0.000%	2026-05-22	Charles Schwab & Co., Inc.
2026-05-18	Lippis Daniel J.Officer	2K	$151K	0.000%	2026-05-18	Charles Schwab & Co., Inc.
2026-05-15	BOBO DONALD E JROfficer	10K	$818K	0.002%	2026-05-15	Charles Schwab & Co., Inc.
2026-05-12	Zovighian Bernard JOfficer, Director	37K	$2.9M	0.006%	2026-05-12	Charles Schwab & Co., Inc.
2026-05-11	Markowitz WayneOfficer	593	$47K	0.000%	2026-05-11	Charles Schwab & Co., Inc.
2026-05-04	Lippis Daniel J.Officer	1K	$86K	0.000%	2026-05-04	Charles Schwab & Co., Inc.
2026-03-11	Lippis Daniel J.Officer	3K	$261K	0.001%	2026-03-11	Charles Schwab & Co., Inc.
2026-03-11	Ullem Scott B.Officer	26K	$2.2M	0.004%	2026-03-11	Charles Schwab & Co., Inc.
2026-02-26	DONALD E BOBO JR.Officer	24K	$2.0M	0.004%	2026-02-25	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-12	Zovighian Bernard JOfficer, Director	22K	$1.7M	0.004%	2026-02-12	Charles Schwab & Co., Inc.
2026-01-06	BOBO DONALD E JROfficer	45K	$3.9M	0.008%	2026-01-06	Charles Schwab & Co., Inc.
2025-12-12	STONE HEISZ LESLIEDirector	3K	$218K	0.000%	2025-12-12	Charles Schwab & Co., Inc.
2025-12-12	BOBO JR FAMILY TRUSTOfficer	6K	$494K	0.001%	2025-12-12	Morgan Stanley Smith Barney LLC Executive Financial Services
2025-12-12	BOBO DONALD E JROfficer	5K	$460K	0.001%	2025-12-12	Charles Schwab & Co., Inc.
2025-12-11	Chopra DaveenOfficer	2K	$169K	0.000%	2025-12-11	Charles Schwab & Co., Inc.
2025-12-10	Zovighian Bernard JOfficer, Director	4K	$322K	0.001%	2025-12-10	Charles Schwab & Co., Inc.
2025-12-10	BOBO DONALD E JROfficer	11K	$951K	0.002%	2025-12-10	Charles Schwab & Co., Inc.
2025-12-08	Markowitz WayneOfficer	583	$50K	0.000%	2025-12-08	Charles Schwab & Co., Inc.
2025-12-08	Zovighian Bernard JOfficer, Director	21K	$1.8M	0.004%	2025-12-08	Charles Schwab & Co., Inc.
2025-11-12	Wood Larry LFormer Affiliate	27K	$2.3M	0.005%	2025-11-11	Charles Schwab & Co., Inc.
2025-11-10	Lippis Daniel J.Officer	3K	$252K	0.001%	2025-11-10	Charles Schwab & Co., Inc.
2025-11-10	Ullem Scott B.Officer	21K	$1.7M	0.004%	2025-11-10	Charles Schwab & Co., Inc.
2025-10-16	Wood Larry LFormer Affiliate	9K	$654K	0.002%	2025-10-16	Charles Schwab & Co., Inc.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

2 holders report 5% or more of EW in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 7.5% of the class (43,477,533 shares), filed 2026-04-29 for an event on 2026-03-31.

Filed	Form	Holder	Shares	Of class	Event
2026-04-29	13G	Vanguard Capital Managementinvestment adviser	43.5M	7.5%	2026-03-31
2026-03-26	13G/Ano. 16	The Vanguard Groupinvestment adviser	0	0.0%	2026-03-13
2025-10-17	13G/Ano. 12	BlackRock, Inc.parent holding company	44.3M	7.5%	2025-09-30

13F holders

Tracked managers holding EW at their latest 13F. JSON

8 of the 30 tracked managers held EW at their latest 13F, $1.15B in total at quarter-end prices. Citadel Advisors is the largest at $361.7M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 4 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Citadel Advisors	2026-06-30	4.0M	$361.7M	0.04%	+3.5M
Millennium Management	2026-06-30	3.6M	$324.3M	0.12%	+1.8M
Point72 Asset Management	2026-06-30	1.8M	$160.5M	0.18%	-52K
Two Sigma Investments	2026-06-30	1.5M	$137.7M	0.10%	+470K
AQR Capital Management	2026-06-30	1.5M	$132.2M	0.05%	-504K
Bridgewater Associates	2026-06-30	275K	$24.9M	0.10%	+103K
Fisher Asset Management	2026-06-30	88K	$7.9M	0.00%	-44K
Renaissance Technologies	2026-06-30	21K	$1.9M	0.00%	-8K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q2 FY 2026 (quarter ended 2026-06-30) Edwards Lifesciences reported revenue of $1.74B, up 13.6% from the same quarter a year earlier, and net income of $241.9M (0.42 diluted EPS). In FY 2025 it generated $1.60B of operating cash flow and spent $893.4M on buybacks. As of 2026-06-30, cash was $2.91B against $598.7M of debt.

Cash: $2.91B
Debt: $598.7M
Equity: $10.62B
Total assets: $13.87B
Shares outstanding: 576,400,000

Quarterly, last 8 quarters

Quarter	Period end	Revenue	Net income	Margin	Diluted EPS
Q2 FY 2026	2026-06-30	$1.74B	$241.9M	13.9%	0.42
Q1 FY 2026	2026-03-31	$1.65B	$380.7M	23.1%	0.66
Q4 FY 2025derived	2025-12-31	$1.57B	$91.2M	5.8%	n/a
Q3 FY 2025	2025-09-30	$1.55B	$291.1M	18.7%	0.50
Q2 FY 2025	2025-06-30	$1.53B	$333.2M	21.7%	0.56
Q1 FY 2025	2025-03-31	$1.41B	$358.0M	25.3%	0.61
Q4 FY 2024	2024-12-31	$1.39B	$385.6M	27.8%	0.65
Q3 FY 2024	2024-09-30	$1.35B	$3.07B	226.7%	5.13

Fiscal years, with buybacks and dividends

Fiscal year	Ends	Revenue	Net income	Operating cash flow	Capex	Buybacks	Dividends
FY 2025	2025-12-31	$6.07B	$1.07B	$1.60B	$260.2M	$893.4M	n/a
FY 2024	2024-12-31	$5.44B	$4.17B	$542.3M	$252.4M	$1.16B	n/a
FY 2023	2023-12-31	$5.01B	$1.40B	$895.8M	$253.0M	$879.6M	n/a
FY 2022	2022-12-31	$4.46B	$1.52B	$1.22B	$244.6M	$1.73B	n/a
FY 2021	2021-12-31	$5.23B	$1.50B	$1.73B	$325.8M	$512.8M	n/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.

What this page is

Edwards Lifesciences in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Edwards Lifesciences (EW), SEC CIK 1099800, listed on NYSE, classified by the SEC as orthopedic, prosthetic & surgical appliances & supplies. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-09.JSON and CSV
Planned sales: SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-31.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-29.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials: SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-23.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-08.JSON and CSV
Company record: EDGAR filing index for CIK 1099800Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as orthopedic, prosthetic & surgical appliances & supplies

Other company pages

Datasets

Frequently Asked Questions

How much of EW is sold short?

9,538,735 shares were held short at the 2026-09-30 settlement, 2.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is EW's daily short volume?

On 2026-10-09, 980,439 of the 1,554,254 EW shares reported to FINRA were sold short, 63.1% of the day's reported volume. Short volume is a flow for one day, not a position.

Does EW have fails to deliver?

The SEC's latest file shows 54 EW shares failed to deliver at settlement 2026-09-09. Fails are reported per settlement date and published twice a month with a lag.

Are EW insiders buying or selling?

Insiders at EW reported 11 open-market sells worth $4.5M in the last 90 days and no open-market buys. Latest filing: Lippis Daniel J. (CVP, TAVR) on 2026-10-08.

Have EW insiders filed to sell?

35 Form 144 notices on file for EW worth $40.4M at the prices reported; 9 in the last 90 days worth $9.2M. Latest: Dahl Andrew M. filed on 2026-08-31 to sell 544 shares ($50K) from 2026-08-31.

Who owns 5% or more of EW?

What did EW report last quarter?

Which tracked 13F managers own EW?

8 of the 30 tracked 13F managers held EW shares at their latest filing, $1.15B in all. The largest: Ken Griffin's Citadel Advisors (4.0M shares, $361.7M), Izzy Englander's Millennium Management (3.6M shares, $324.3M), Steve Cohen's Point72 Asset Management (1.8M shares, $160.5M), Two Sigma Investments (1.5M shares, $137.7M), Cliff Asness's AQR Capital Management (1.5M shares, $132.2M), Ray Dalio's Bridgewater Associates (275K shares, $24.9M). The table above lists all 8.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.